tirzepatide weight loss shot Can Help You Lose Weight? New drug Tirzepatide could be

It affects around 36% of people with type 2 diabetes

Is combining them synergistic

Contraindications: Personal or family history of medullary thyroid carcinoma (MTC) Multiple endocrine neoplasia syndrome type 2 (MEN 2) Hypersensitivity to semaglutide or any excipient Not recommended in pregnancy or breastfeeding Side Effects: Very common : Nausea, vomiting, diarrhea, constipation Common : Abdominal pain, headache, fatigue, decreased appetite Rare : Pancreatitis, gallbladder issues Serious risks : Thyroid C-cell tumors (in animal studies), renal events in context of dehydration WEGOVY contains semaglutide , a GLP-1 receptor agonist that is long-acting and structurally modified for stability and sustained action

The appetite suppression that tirzepatide provided will fade as the compound clears your system

Read and watch more here: Can weight loss injection tackle UKs 40bn obesity bill